IL157757A0 - Nicotine receptor agonists for the treatment of inflammatory diseases - Google Patents

Nicotine receptor agonists for the treatment of inflammatory diseases

Info

Publication number
IL157757A0
IL157757A0 IL15775702A IL15775702A IL157757A0 IL 157757 A0 IL157757 A0 IL 157757A0 IL 15775702 A IL15775702 A IL 15775702A IL 15775702 A IL15775702 A IL 15775702A IL 157757 A0 IL157757 A0 IL 157757A0
Authority
IL
Israel
Prior art keywords
agonists
receptor agonists
pulmonary
nicotine receptor
diseases
Prior art date
Application number
IL15775702A
Other languages
English (en)
Original Assignee
Univ Laval
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Laval filed Critical Univ Laval
Publication of IL157757A0 publication Critical patent/IL157757A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15775702A 2001-03-23 2002-03-25 Nicotine receptor agonists for the treatment of inflammatory diseases IL157757A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002341952A CA2341952A1 (fr) 2001-03-23 2001-03-23 Agonistes du recepteur de la nicotine pour le traitement des maladies pulmonaires inflammatoires
PCT/CA2002/000412 WO2002076434A2 (fr) 2001-03-23 2002-03-25 Traitement d'affections inflammatoires au moyen d'agonistes des récepteurs nicotiniques

Publications (1)

Publication Number Publication Date
IL157757A0 true IL157757A0 (en) 2004-03-28

Family

ID=4168679

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15775702A IL157757A0 (en) 2001-03-23 2002-03-25 Nicotine receptor agonists for the treatment of inflammatory diseases

Country Status (18)

Country Link
US (3) US7601720B2 (fr)
EP (1) EP1370264B1 (fr)
JP (1) JP4377586B2 (fr)
CN (1) CN100528159C (fr)
AT (1) ATE378051T1 (fr)
AU (1) AU2002249023B2 (fr)
BR (1) BR0208305A (fr)
CA (1) CA2341952A1 (fr)
DE (1) DE60223508T2 (fr)
DK (1) DK1370264T3 (fr)
ES (1) ES2295331T3 (fr)
IL (1) IL157757A0 (fr)
MX (1) MXPA03008423A (fr)
NO (1) NO331674B1 (fr)
NZ (1) NZ528042A (fr)
PL (1) PL207880B1 (fr)
RU (1) RU2299731C2 (fr)
WO (1) WO2002076434A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188043B2 (en) 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
CA2341952A1 (fr) 2001-03-23 2002-09-23 Universite Laval Agonistes du recepteur de la nicotine pour le traitement des maladies pulmonaires inflammatoires
US20050130990A1 (en) * 2001-03-23 2005-06-16 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
US7045534B2 (en) * 2002-02-12 2006-05-16 The Board Of Trustees Of The Leland Stanford Junior University Methods of reducing angiogenesis
US8039459B2 (en) 2004-07-15 2011-10-18 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
US8557804B2 (en) 2002-03-25 2013-10-15 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
US20040010018A1 (en) * 2002-05-15 2004-01-15 Rueter Lynne E. Treatment of neuropathic pain
US7238715B2 (en) 2002-12-06 2007-07-03 The Feinstein Institute For Medical Research Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
PL364348A1 (en) * 2004-01-12 2005-07-25 PHARMENA Sp.z o.o. Application of quaternary pyridine salts as vessel protection agent
CA2573977C (fr) * 2004-07-15 2012-04-10 Universite Laval Agonistes du recepteur de nicotine pour le traitement de maladies inflammatoires
US8378109B2 (en) 2004-12-07 2013-02-19 The Regents Of The University Of California Labeled ALPHA4BETA2 ligands and methods therefor
US9029557B2 (en) 2004-12-07 2015-05-12 The Regents Of The University Of California Labeled A4B2 ligands and methods therefor
US8316104B2 (en) 2005-11-15 2012-11-20 California Institute Of Technology Method and apparatus for collaborative system
CA2633655A1 (fr) * 2005-12-19 2007-07-05 Comentis, Inc. Preparations de mecamylamine topique pour administration oculaire et utilisations de celles-ci
CN101437515B (zh) * 2006-05-08 2016-04-20 阿图罗·索利斯埃雷拉 烟碱、其类似物、其前体或其衍生物用于通过以预防形式或治疗形式参与的α-MSH改善治疗各种病理过程的应用
DK2549995T3 (da) * 2010-03-23 2021-05-25 Philip Morris Products Sa Brug af anatabin til behandling af inflammation og metoder til syntetisering af anatabin
US8207346B2 (en) 2010-03-23 2012-06-26 Rock Creek Pharmaceuticals, Inc. Methods of synthesizing anatabine
CN108578405A (zh) 2011-08-29 2018-09-28 菲利普莫里斯产品有限公司 用于抗炎支持的产品
WO2015149178A1 (fr) 2014-04-03 2015-10-08 UNIVERSITé LAVAL Méthode d'utilisation de composés d'homopipérazinium dans le traitement du cancer
RU2593585C1 (ru) * 2015-06-26 2016-08-10 Общество с ограниченной ответственностью "Ритек-Фарма" Способ лечения табакокурения и других форм никотиновой зависимости, а также профилактики рецидивов табакокурения
CN113992687B (zh) * 2021-12-28 2022-04-08 浙江宇视科技有限公司 智能业务集群调度方法、装置、电子设备及存储介质

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2594296A (en) * 1948-06-24 1952-04-29 Aerosol Corp Lobeline aerosol dilating medicament
US2778772A (en) * 1952-11-04 1957-01-22 Parke Davis & Co Dimethyl phenyl piperazinium iodide compositions and process for stimulation of the autonomic ganglion system
US3402039A (en) * 1966-12-05 1968-09-17 Dow Chemical Co Piperazinium salts as plant stunting agents
US5977144A (en) * 1992-08-31 1999-11-02 University Of Florida Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
WO1996015117A1 (fr) * 1994-11-11 1996-05-23 Nippon Soda Co., Ltd. Compose optiquement actif
US5846983A (en) 1996-02-09 1998-12-08 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
RU2127123C1 (ru) 1996-06-04 1999-03-10 Московское производственное химико-фармацевтическое объединение им.Н.А.Семашко Противоастматическое лекарственное средство в виде таблеток и способ получения таблеток
GB9614902D0 (en) 1996-07-16 1996-09-04 Rhodes John Sustained release composition
US5981549A (en) * 1997-02-14 1999-11-09 Synapse Pharmaceutical International Method for controlling or alleviating the symptoms of respiratory disease and allergies
ATE491689T1 (de) 1997-10-27 2011-01-15 Neurosearch As Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
EP1434573A2 (fr) 1998-10-20 2004-07-07 Omeros Corporation Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation
ATE488250T1 (de) * 1999-03-02 2010-12-15 Centocor Inc Antikörper gegen tnf alpha zur therapie von steroidresistentem asthma
AU764627B2 (en) * 1999-06-21 2003-08-28 Bristol-Myers Squibb Company Dihydropyrazine derivatives as NPY antagonists
SE0001075D0 (sv) 1999-09-01 2000-03-27 Laszlo Bense Användning av åtminstone ett nikotinbaserat ämne och/eller ett ur detta ämne framställt ämne för tillverkning av ett medikament samt förfarande för behandling av obstruktiva lungsjukdomar
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
US6610713B2 (en) * 2000-05-23 2003-08-26 North Shore - Long Island Jewish Research Institute Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
DE60132710T2 (de) 2000-12-01 2008-06-12 Neurosearch A/S 3-substituierte chinuclidine und ihre verwendung als nikotinische agonisten
US20020160988A1 (en) * 2001-02-20 2002-10-31 Israel Institute For Biological Research Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
BR0208303A (pt) 2001-03-22 2004-03-09 Battelle Memorial Institute Formações liquidas para pulverização eletroidrodin mica contendo polìmero e partìculas suspensas
US20050130990A1 (en) * 2001-03-23 2005-06-16 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
CA2341952A1 (fr) 2001-03-23 2002-09-23 Universite Laval Agonistes du recepteur de la nicotine pour le traitement des maladies pulmonaires inflammatoires
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
GB2381750A (en) 2001-10-10 2003-05-14 Inspire Pharmaceuticals Inc Treatment for enhancing joint lubrication
US20030236287A1 (en) * 2002-05-03 2003-12-25 Piotrowski David W. Positive allosteric modulators of the nicotinic acetylcholine receptor
TW200412945A (en) * 2002-10-25 2004-08-01 Upjohn Co Quaternary ammonium compounds
AU2003267802A1 (en) * 2002-10-29 2004-05-25 Pharmacia & Upjohn Company Llc Quaternary ammonium compounds as muscarinic receptor antagonists
CA2498189A1 (fr) * 2002-10-29 2004-05-13 Pharmacia & Upjohn Company Llc Composes d'ammonium quaternaire
US20050075323A1 (en) * 2003-03-05 2005-04-07 Pfizer Inc Beta3 adrenergic receptor agonists and uses thereof
FR2852830B1 (fr) 2003-03-24 2008-04-18 Oreal Composition de teinture des fibres keratiniques comprenant un derive de para-phenylenediamine cationique substitue par un cycle diazacyclohexane ou diazacycloheptane
US20040242569A1 (en) * 2003-04-15 2004-12-02 Pfizer Inc. Quatemary ammonium compounds
CA2573977C (fr) 2004-07-15 2012-04-10 Universite Laval Agonistes du recepteur de nicotine pour le traitement de maladies inflammatoires

Also Published As

Publication number Publication date
EP1370264A2 (fr) 2003-12-17
RU2003131178A (ru) 2005-04-10
DE60223508T2 (de) 2008-09-25
NZ528042A (en) 2005-10-28
EP1370264B1 (fr) 2007-11-14
US20040132737A1 (en) 2004-07-08
CA2341952A1 (fr) 2002-09-23
PL365224A1 (en) 2004-12-27
AU2002249023B2 (en) 2006-02-02
DE60223508D1 (de) 2007-12-27
CN100528159C (zh) 2009-08-19
RU2299731C2 (ru) 2007-05-27
WO2002076434A3 (fr) 2003-07-17
ES2295331T3 (es) 2008-04-16
JP4377586B2 (ja) 2009-12-02
US20100227871A1 (en) 2010-09-09
BR0208305A (pt) 2004-03-09
NO331674B1 (no) 2012-02-20
NO20034185L (no) 2003-11-24
US7601720B2 (en) 2009-10-13
US8377936B2 (en) 2013-02-19
US20110245270A1 (en) 2011-10-06
ATE378051T1 (de) 2007-11-15
PL207880B1 (pl) 2011-02-28
MXPA03008423A (es) 2004-03-19
DK1370264T3 (da) 2008-03-17
JP2004523588A (ja) 2004-08-05
CN1498108A (zh) 2004-05-19
WO2002076434A2 (fr) 2002-10-03
NO20034185D0 (no) 2003-09-19

Similar Documents

Publication Publication Date Title
IL157757A0 (en) Nicotine receptor agonists for the treatment of inflammatory diseases
MXPA03010731A (es) Combinacion de agonista del receptor a2a de adenosina y tiotropio o sus derivados para tratar enfermedades obstructivas de vias aereas.
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
IL151791A0 (en) Pharmaceutical composition for the treatment of respiratory diseases
WO2004041183A3 (fr) Procedes de traitement de troubles fibrotiques pulmonaires
WO2003000241A3 (fr) Nouvelles compositions de medicament a base d'anticholinergiques, de corticosteroides et d'agents beta-mimetiques
ATE330589T1 (de) Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege
WO2006037031A3 (fr) Formulations et procedes destines au traitement de maladies inflammatoires
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
WO2007092556A3 (fr) Procédé d'utilisation de l'acide abscisique pour le traitement et la prévention de maladies et de troubles
EP1251126A3 (fr) Derives de benzenesulfonyle a substitution fluor pour le traitment d'inflammation
WO2006115770A3 (fr) Preparations pharmaceutiques d'olazanpine en comprimes a desintegration orale
EP1348466A3 (fr) Méthode de traitement du douleur avec adenosine tetraphosphates
CA2595363A1 (fr) Methodes et mareriaux a base de trans-clomiphene permettant de traiter la sterilite masculine
JP6778200B2 (ja) Ｓｐｉｒａｎｔｈｅｓ ｓｉｎｅｎｓｉｓ抽出物を含有する組成物およびその薬学的適用
WO2004056310A3 (fr) Procedes de diagnostic et de traitement de maladies pulmonaires interstitielles
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
WO2006072093A3 (fr) Traitement de la maladie du greffon contre l'hote et de la leucemie par le diproprionate de beclomethasone et la prednisone
WO2001045685A3 (fr) Formulations d'agonistes adenosine a1
CA2441096A1 (fr) Traitement d'affections inflammatoires au moyen d'agonistes des recepteurs nicotiniques
MX2023005801A (es) Derivados de ftalazina como inhibidores de purinoceptor 3 de p2x (p2x3).
AP2004003053A0 (en) Pharmaceutical combinations of adenosine A-2A and beta-2-adrenergic receptor agonists
WO2002053099A3 (fr) Methodes et compositions de traitement d'une parodontopathie
WO2005011615A3 (fr) Combinaison de deshydroepiandrosterone ou de sulfate de deshydroepiandrosterone avec un bronchodilatateur anticholinergique pour le traitement de l'asthme ou de la bronchopneumopathie obstructive chronique
CA2506956A1 (fr) Combinaison synergique comprenant du roflumilast et du (r,r)-formoterol

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees